Global Cell Therapy Market Analysis 2019

The Cell Therapy market is expected to reach $9.76 billion by 2026 growing at a CAGR of 7.2% from 2018 to 2026. Cell therapy is a technology which relies on replacing diseased or dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy finds its application in the development of regenerative medicines which is a multidisciplinary area aimed at maintenance, improvement, or restoration of a cell, tissue, or organ function using methods mainly related to cell therapy. Factors such as rising funding from the government as well as private organizations to support cell therapy clinical trials, growing adoption of regenerative medicine and increase in the incidence of diseases such as cancer, cardiac abnormalities are fuelling the market growth. However, the implementation of stringent government regulations regarding the use of cell therapy is anticipated to restrict the growth of the market. By Therapy Type, Autologous therapies are going have a significant rate during the forecast period owing to several advantages offered by them such as availability, lower risk of life-threatening complications, low rate of graft failure, low mortality rate, higher affordability and high survival rate of patients. Autologous cell therapy is a branch of regenerative medicine. It involves biologic cell-based therapies to cure various diseases related to oncology, dermatology, and neurology, among others. The key vendors mentioned are MEDIPOST, AlloCure, Cell Medica, Kolon TissueGene, Inc., Arteriocyte Medical Systems, Forticell Bioscience, Athersys Inc., Stemedica Cell Technologies, Inc., Vericel Corporation, Baxter Healthcare Corporation, JCR Pharmaceuticals Co., Ltd., Osiris Therapeutics, Inc., Bone Therapeutics, Cellerant Therapeutics, Celgene Corporation, PHARMICELL Co., Ltd, FibrocellScinence, NuVasive, Inc, and ANTEROGEN.CO.,LTD. Therapy Types Covered: • Autologous Therapies • Allogenic Therapies Cell Types Covered: • Non-Stem Cell • Stem Cell Use & Types Covered • Research-Use • Clinical-Use Therapeutics Covered: • Musculoskeletal Disorders • Dermatology • Malignancies • Autoimmune Disorders • Other Therapeutics Technologies Covered: • Cell Immortalization Technology • Genome Editing Technology • Viral Vector Technology Products Covered • Equipment • Consumables • Software • Other Services Cell Sources Covered: • Adipose Tissue • Umbilical Cord Blood-Derived Cells • Bone Marrow Techniques Covered: • Fibroblast Cell Therapy • Cell Vaccine • Stem Cell Therapy • Chondrocyte Cell Therapy • Adoptive Cell Transfer (ACT) Applications Covered • Cardiovascular Disease (CVD) • Oncology • Wound Healing • Orthopaedic End Users Covered: • Regenerative Medicine Centers • Academic & Research Institutes • Hospital & Clinics Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analysed during the forecast period

1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Cell Therapy Market, By Therapy Type
5.1 Introduction
5.2 Autologous Therapies
5.3 Allogenic Therapies

6 Global Cell Therapy Market, By Cell Type
6.1 Introduction
6.2 Non-Stem Cell
6.3 Stem Cell

7 Global Cell Therapy Market, By Use & Type
7.1 Introduction
7.2 Research-Use
7.3 Clinical-Use

8 Global Cell Therapy Market, By Therapeutic
8.1 Introduction
8.2 Musculoskeletal Disorders
8.3 Dermatology
8.4 Malignancies
8.5 Autoimmune Disorders
8.6 Other Therapeutics

9 Global Cell Therapy Market, By Technology
9.1 Introduction
9.2 Cell Immortalization Technology
9.3 Genome Editing Technology
9.4 Viral Vector Technology

10 Global Cell Therapy Market, By Product
10.1 Introduction
10.2 Equipment
10.3 Consumables
10.4 Software
10.5 Other Services

11 Global Cell Therapy Market, By Cell Source
11.1 Introduction
11.2 Adipose Tissue
11.3 Umbilical Cord Blood-Derived Cells
11.4 Bone Marrow

12 Global Cell Therapy Market, By Technique
12.1 Introduction
12.2 Fibroblast Cell Therapy
12.3 Cell Vaccine
12.4 Stem Cell Therapy
12.5 Chondrocyte Cell Therapy
12.6 Adoptive Cell Transfer (ACT)

13 Global Cell Therapy Market, By Application
13.1 Introduction
13.2 Cardiovascular Disease (CVD)
13.3 Oncology
13.4 Wound Healing
13.5 Orthopaedic

14 Global Cell Therapy Market, By End User
14.1 Introduction
14.2 Regenerative Medicine Centers
14.3 Academic & Research Institutes
14.4 Hospital & Clinics

15 Global Cell Therapy Market, By Geography
15.1 North America
15.2 Europe
15.3 Asia Pacific
15.4 South America
15.5 Middle East & Africa

16 Strategic Benchmarking

17 Vendors Landscape
17.1 MEDIPOST
17.2 AlloCure
17.3 Cell Medica
17.4 Kolon TissueGene, Inc.
17.5 Arteriocyte Medical Systems
17.6 Forticell Bioscience
17.7 Athersys Inc.
17.8 Stemedica Cell Technologies, Inc.
17.9 Vericel Corporation
17.10 Baxter Healthcare Corporation
17.11 JCR Pharmaceuticals Co., Ltd.
17.12 Osiris Therapeutics, Inc.
17.13 Bone Therapeutics
17.14 Cellerant Therapeutics
17.15 Celgene Corporation
17.16 PHARMICELL Co., Ltd
17.17 FibrocellScinence
17.18 NuVasive, Inc
17.19 ANTEROGEN.CO.,LTD

List of Data Tables
Table 1 Global Cell Therapy Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Cell Therapy Market Outlook, By Therapy Type (2016-2026) ($MN)
Table 3 Global Cell Therapy Market Outlook, By Autologous Therapies (2016-2026) ($MN)
Table 4 Global Cell Therapy Market Outlook, By Allogenic Therapies (2016-2026) ($MN)
Table 5 Global Cell Therapy Market Outlook, By Cell Type (2016-2026) ($MN)
Table 6 Global Cell Therapy Market Outlook, By Non-Stem Cell (2016-2026) ($MN)
Table 7 Global Cell Therapy Market Outlook, By Stem Cell (2016-2026) ($MN)
Table 8 Global Cell Therapy Market Outlook, By Use & Type (2016-2026) ($MN)
Table 9 Global Cell Therapy Market Outlook, By Research-Use (2016-2026) ($MN)
Table 10 Global Cell Therapy Market Outlook, By Clinical-Use (2016-2026) ($MN)
Table 11 Global Cell Therapy Market Outlook, By Therapeutic (2016-2026) ($MN)
Table 12 Global Cell Therapy Market Outlook, By Musculoskeletal Disorders (2016-2026) ($MN)
Table 13 Global Cell Therapy Market Outlook, By Dermatology (2016-2026) ($MN)
Table 14 Global Cell Therapy Market Outlook, By Malignancies (2016-2026) ($MN)
Table 15 Global Cell Therapy Market Outlook, By Autoimmune Disorders (2016-2026) ($MN)
Table 16 Global Cell Therapy Market Outlook, By Other Therapeutics (2016-2026) ($MN)
Table 17 Global Cell Therapy Market Outlook, By Technology (2016-2026) ($MN)
Table 18 Global Cell Therapy Market Outlook, By Cell Immortalization Technology (2016-2026) ($MN)
Table 19 Global Cell Therapy Market Outlook, By Genome Editing Technology (2016-2026) ($MN)
Table 20 Global Cell Therapy Market Outlook, By Viral Vector Technology (2016-2026) ($MN)
Table 21 Global Cell Therapy Market Outlook, By Product (2016-2026) ($MN)
Table 22 Global Cell Therapy Market Outlook, By Equipment (2016-2026) ($MN)
Table 23 Global Cell Therapy Market Outlook, By Consumables (2016-2026) ($MN)
Table 24 Global Cell Therapy Market Outlook, By Software (2016-2026) ($MN)
Table 25 Global Cell Therapy Market Outlook, By Other Services (2016-2026) ($MN)
Table 26 Global Cell Therapy Market Outlook, By Cell Source (2016-2026) ($MN)
Table 27 Global Cell Therapy Market Outlook, By Adipose Tissue (2016-2026) ($MN)
Table 28 Global Cell Therapy Market Outlook, By Umbilical Cord Blood-Derived Cells (2016-2026) ($MN)
Table 29 Global Cell Therapy Market Outlook, By Bone Marrow (2016-2026) ($MN)
Table 30 Global Cell Therapy Market Outlook, By Technique (2016-2026) ($MN)
Table 31 Global Cell Therapy Market Outlook, By Fibroblast Cell Therapy (2016-2026) ($MN)
Table 32 Global Cell Therapy Market Outlook, By Cell Vaccine (2016-2026) ($MN)
Table 33 Global Cell Therapy Market Outlook, By Stem Cell Therapy (2016-2026) ($MN)
Table 34 Global Cell Therapy Market Outlook, By Chondrocyte Cell Therapy (2016-2026) ($MN)
Table 35 Global Cell Therapy Market Outlook, By Adoptive Cell Transfer (ACT) (2016-2026) ($MN)
Table 36 Global Cell Therapy Market Outlook, By Application (2016-2026) ($MN)
Table 37 Global Cell Therapy Market Outlook, By Cardiovascular Disease (CVD) (2016-2026) ($MN)
Table 38 Global Cell Therapy Market Outlook, By Oncology (2016-2026) ($MN)
Table 39 Global Cell Therapy Market Outlook, By Wound Healing (2016-2026) ($MN)
Table 40 Global Cell Therapy Market Outlook, By Orthopedic (2016-2026) ($MN)
Table 41 Global Cell Therapy Market Outlook, By End User (2016-2026) ($MN)
Table 42 Global Cell Therapy Market Outlook, By Regenerative Medicine Centers (2016-2026) ($MN)
Table 43 Global Cell Therapy Market Outlook, By Academic & Research Institutes (2016-2026) ($MN)
Table 44 Global Cell Therapy Market Outlook, By Hospital & Clinics (2016-2026) ($MN)
Table 45 North America Cell Therapy Market Outlook, By Therapy Type (2016-2026) ($MN)
Table 46 North America Cell Therapy Market Outlook, By Cell Type (2016-2026) ($MN)
Table 47 North America Cell Therapy Market Outlook, By Use & Type (2016-2026) ($MN)
Table 48 North America Cell Therapy Market Outlook, By Therapeutic (2016-2026) ($MN)
Table 49 North America Cell Therapy Market Outlook, By Technology (2016-2026) ($MN)
Table 50 North America Cell Therapy Market Outlook, By Product (2016-2026) ($MN)
Table 51 North America Cell Therapy Market Outlook, By Cell Source (2016-2026) ($MN)
Table 52 North America Cell Therapy Market Outlook, By Technique (2016-2026) ($MN)
Table 53 North America Cell Therapy Market Outlook, By Application (2016-2026) ($MN)
Table 54 North America Cell Therapy Market Outlook, By End User (2016-2026) ($MN)
Table 55 Europe Cell Therapy Market Outlook, By Therapy Type (2016-2026) ($MN)
Table 56 Europe Cell Therapy Market Outlook, By Cell Type (2016-2026) ($MN)
Table 57 Europe Cell Therapy Market Outlook, By Use & Type (2016-2026) ($MN)
Table 58 Europe Cell Therapy Market Outlook, By Therapeutic (2016-2026) ($MN)
Table 59 Europe Cell Therapy Market Outlook, By Technology (2016-2026) ($MN)
Table 60 Europe Cell Therapy Market Outlook, By Product (2016-2026) ($MN)
Table 61 Europe Cell Therapy Market Outlook, By Cell Source (2016-2026) ($MN)
Table 62 Europe Cell Therapy Market Outlook, By Technique (2016-2026) ($MN)
Table 63 Europe Cell Therapy Market Outlook, By Application (2016-2026) ($MN)
Table 64 Europe Cell Therapy Market Outlook, By End User (2016-2026) ($MN)
Table 65 Asia Pacific Cell Therapy Market Outlook, By Therapy Type (2016-2026) ($MN)
Table 66 Asia Pacific Cell Therapy Market Outlook, By Cell Type (2016-2026) ($MN)
Table 67 Asia Pacific Cell Therapy Market Outlook, By Use & Type (2016-2026) ($MN)
Table 68 Asia Pacific Cell Therapy Market Outlook, By Therapeutic (2016-2026) ($MN)
Table 69 Asia Pacific Cell Therapy Market Outlook, By Technology (2016-2026) ($MN)
Table 70 Asia Pacific Cell Therapy Market Outlook, By Product (2016-2026) ($MN)
Table 71 Asia Pacific Cell Therapy Market Outlook, By Cell Source (2016-2026) ($MN)
Table 72 Asia Pacific Cell Therapy Market Outlook, By Technique (2016-2026) ($MN)
Table 73 Asia Pacific Cell Therapy Market Outlook, By Application (2016-2026) ($MN)
Table 74 Asia Pacific Cell Therapy Market Outlook, By End User (2016-2026) ($MN)
Table 75 South America Cell Therapy Market Outlook, By Therapy Type (2016-2026) ($MN)
Table 76 South America Cell Therapy Market Outlook, By Cell Type (2016-2026) ($MN)
Table 77 South America Cell Therapy Market Outlook, By Use & Type (2016-2026) ($MN)
Table 78 South America Cell Therapy Market Outlook, By Therapeutic (2016-2026) ($MN)
Table 79 South America Cell Therapy Market Outlook, By Technology (2016-2026) ($MN)
Table 80 South America Cell Therapy Market Outlook, By Product (2016-2026) ($MN)
Table 81 South America Cell Therapy Market Outlook, By Cell Source (2016-2026) ($MN)
Table 82 South America Cell Therapy Market Outlook, By Technique (2016-2026) ($MN)
Table 83 South America Cell Therapy Market Outlook, By Application (2016-2026) ($MN)
Table 84 South America Cell Therapy Market Outlook, By End User (2016-2026) ($MN)
Table 85 Middle East & Africa Cell Therapy Market Outlook, By Therapy Type (2016-2026) ($MN)
Table 86 Middle East & Africa Cell Therapy Market Outlook, By Cell Type (2016-2026) ($MN)
Table 87 Middle East & Africa Cell Therapy Market Outlook, By Use & Type (2016-2026) ($MN)
Table 88 Middle East & Africa Cell Therapy Market Outlook, By Therapeutic (2016-2026) ($MN)
Table 89 Middle East & Africa Cell Therapy Market Outlook, By Technology (2016-2026) ($MN)
Table 90 Middle East & Africa Cell Therapy Market Outlook, By Product (2016-2026) ($MN)
Table 91 Middle East & Africa Cell Therapy Market Outlook, By Cell Source (2016-2026) ($MN)
Table 92 Middle East & Africa Cell Therapy Market Outlook, By Technique (2016-2026) ($MN)
Table 93 Middle East & Africa Cell Therapy Market Outlook, By Application (2016-2026) ($MN)
Table 94 Middle East & Africa Cell Therapy Market Outlook, By End User (2016-2026) ($MN)